论文部分内容阅读
目的对我院抗幽门螺杆菌的门诊处方进行调查分析,为临床合理用药提供参考。方法利用医院信息系统调取我院2015年门诊抗幽门螺杆菌处方共1 019张,分析抗幽门螺杆菌药物的使用情况。结果铋剂四联疗法临床使用最多,其中铋剂+标准三联方案占36.11%,单张处方金额平均为262.76元,多为7 d疗程。抗菌药物中使用率最高的为克拉霉素缓释片,质子泵抑制剂中使用率最高的为雷贝拉唑胶囊,抗酸及胃黏膜保护药中使用率最高的为胶体果胶铋胶囊。结论抗幽门螺杆菌临床治疗方案众多且在不断改进,我院门诊处方在疗程、药品选择等方面有待进一步完善。
Objective To investigate the outpatient prescription of anti-Helicobacter pylori in our hospital to provide reference for clinical rational drug use. Methods A total of 1 019 prescriptions for anti-Helicobacter pylori in our hospital were retrieved by hospital information system to analyze the use of anti-Helicobacter pylori drugs. Results The bismuth quadruple therapy was the most widely used, with bismuth + standard triple therapy accounting for 36.11%. The average amount of leaflets prescription was 262.76 yuan, mostly for 7 days. The highest usage rate of antibacterials was clarithromycin sustained release tablets, the highest usage rate of proton pump inhibitors was rabeprazole capsules, and the highest usage rate of antibacterial and gastric mucosal protective drugs was colloidal pectin bismuth capsules. Conclusion There are many clinical treatment programs for Helicobacter pylori infection and their continuous improvements. The outpatient prescriptions in our hospital need to be further improved in terms of course of treatment and drug selection.